Bright Minds Biosciences Inc. DRUG
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 216.77M | 221.86M | 64.95M | 59.52M | 37.68M |
| Total Receivables | 776.00K | 816.60K | 366.60K | 296.60K | 199.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 952.90K | 1.05M | 902.30K | 709.30K | 519.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 218.49M | 223.73M | 66.21M | 60.53M | 38.40M |
|
|
|||||
| Total Current Assets | 218.49M | 223.73M | 66.21M | 60.53M | 38.40M |
| Net Property, Plant & Equipment | 37.30K | 51.90K | 67.20K | 80.40K | 94.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 218.53M | 223.78M | 66.28M | 60.61M | 38.49M |
|
|
|||||
| Total Accounts Payable | 1.67M | 2.60M | 1.04M | 1.23M | 374.50K |
| Total Accrued Expenses | 80.10K | 86.40K | 45.90K | 388.10K | 11.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 46.20K | 58.80K | 64.30K | 60.70K | 57.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.79M | 2.75M | 1.15M | 1.68M | 443.60K |
|
|
|||||
| Total Current Liabilities | 1.79M | 2.75M | 1.15M | 1.68M | 443.60K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 12.20K | 29.60K | 46.10K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.79M | 2.75M | 1.17M | 1.71M | 489.70K |
|
|
|||||
| Common Stock & APIC | 257.71M | 262.05M | 99.75M | 88.49M | 65.92M |
| Retained Earnings | -47.18M | -46.28M | -39.49M | -33.44M | -31.16M |
| Treasury Stock & Other | 6.21M | 5.27M | 4.85M | 3.86M | 3.24M |
| Total Common Equity | 216.74M | 221.03M | 65.12M | 58.90M | 38.00M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 216.74M | 221.03M | 65.12M | 58.90M | 38.00M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 216.74M | 221.03M | 65.12M | 58.90M | 38.00M |
|
|
|||||